Innovation and Entrepreneurship Research

From Scientific Research to Healthcare Markets: Empirical Essays on the Economics of Pharmaceutical Innovation

Improving health is a fundamental goal of modern societies. New pharmaceutical treatments have contributed significantly to progress in public health and life expectancy (Lichtenberg 2019). However, the development of new drugs is a costly endeavor. Therefore, how to effectively and efficiently promote biomedical science and pharmaceutical innovation is a first-order economic and policy concern. This dissertation sheds light on three stimuli for biomedical science and pharmaceutical innovation.


  • Byrski, Dennis; Wang, Lucy X. (2023). Marketing Authorization and Strategic Patenting: Evidence from Pharmaceuticals, SSRN Working Paper, No. 4638115, DOI.
  • Byrski, Dennis (2021). From Scientific Research to Healthcare Markets: Empirical Essays on the Economics of Pharmaceutical Innovation, Dissertation, LMU München: Faculty of Economics, DOI.
  • Byrski, Dennis; Gaessler, Fabian; Higgins, Matthew J. (2021). Market Size and Research: Evidence from the Pharmaceutical Industry, Max Planck Institute for Innovation & Competition Research Paper, No. 21-16, DOI, and NBER Working Paper, No. w28858, DOI.
  • Baruffaldi, Stefano H.; Byrski, Dennis; Gaessler, Fabian (2020). Fire and Mice: The Effect of Supply Shocks on Basic Science, Academy of Management Proceedings, 2020 (1), 14405, DOI.


Doctoral Student

Dennis Byrski

Doctoral Supervisor

Prof. Dietmar Harhoff, Ph.D.
Prof. Dr. Monika Schnitzer (LMU)

Fields of Research